Get the Stockscreener App
0.00
100.00%
-5.34
Generation Bio Co stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
See More
Previous Close:
$5.34
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$35.98M
Revenue:
$15.27M
Net Income/Loss:
$-62.63M
P/E Ratio:
0.00
EPS:
-7.3629
Net Cash Flow:
$-114.74M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$6.95
Generation Bio Co Stock (GBIO) Company Profile
Name
Generation Bio Co
Sector
Industry
Phone
857-529-5908
Address
301 BINNEY STREET, CAMBRIDGE
Compare GBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.00 | 35.98M | 15.27M | -62.63M | -114.74M | -7.3629 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.13 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.61 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
708.85 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.23 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
285.30 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Downgrade | Jefferies | Buy → Hold |
| Dec-16-25 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-13-25 | Downgrade | Wedbush | Outperform → Neutral |
| Oct-19-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Dec-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-08-21 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-21 | Initiated | William Blair | Outperform |
| Feb-18-21 | Initiated | Needham | Buy |
| Jul-07-20 | Initiated | Cowen | Outperform |
| Jul-07-20 | Initiated | JP Morgan | Overweight |
| Jul-07-20 | Initiated | Jefferies | Buy |
| Jul-07-20 | Initiated | Wedbush | Outperform |
View All
Generation Bio Co Stock (GBIO) Latest News
Will Generation Bio Co benefit from green energy policiesTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
How interest rate cuts could boost Generation Bio Co. stockDividend Hike & AI Based Trade Execution Alerts - Naître et grandir
Performance Recap: Can Generation Bio Co grow without external fundingMarket Growth Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Generation Bio (GBIO) to Release Earnings on Thursday - Defense World
Sironix Renewables Launches Furasoft™Next Generation, Bio-Based Surfactant for Personal Care - The Manila Times
Generation Bio Co. (NASDAQ:GBIO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
GBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MegazoneCloud to work with CellKey AI on global business for bio AI solutions - 디지털투데이
[15-12G] Generation Bio Co. SEC Filing - Stock Titan
T. Rowe Price holds 3.1% of Generation Bio (GBIO) shares - Stock Titan
Will Generation Bio Co. benefit from green energy policiesJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - mfd.ru
Generation Bio (NASDAQ:GBIO) Stock Rating Upgraded by Wall Street Zen - Defense World
Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com Australia
Bear Alert: Why is Generation Bio Co. stock going downJuly 2025 Analyst Calls & Stock Portfolio Risk Management - mfd.ru
Why Generation Bio Co. stock remains undervaluedWeekly Gains Summary & Fast Moving Stock Watchlists - mfd.ru
Baselake exits Generation Bio (NASDAQ: GBIO) reporting 0% ownership stake - Stock Titan
New Highs: What drives Generation Bio Co.’s stock priceShort Setup & Weekly Sector Rotation Insights - mfd.ru
Generation Bio pays landlord $21.5M to escape lease early after Xoma buyout - The Business Journals
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share By Investing.com - Investing.com South Africa
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Generation Bio; GBIO delisted from Nasdaq - Investing.com
XOMA Completes Acquisition and Delisting of Generation Bio - TipRanks
XOMA Royalty Completes Generation Bio Acquisition and Merger - TipRanks
Generation Bio Announced Transfer or Voluntary Withdrawal of Listing - TradingView
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - The Manila Times
XOMA Royalty Corporation Completes Acquisition of Generation Bio Co. Through Tender Offer - Quiver Quantitative
Generation Bio investors cashed out at $4.2913 a share in XOMA takeover - Stock Titan
Wilson Disease Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Deep Genomics Inc, DepYmed Inc, Enveda Biosciences Inc, Generation Bio Co, Vivet Therapeutics - Barchart.com
Generation Bio Co. (NASDAQ:GBIO) Given Average Rating of “Hold” by Brokerages - Defense World
Buyout Rumor: How correlated is SQFTW to the S P5002025 Key Highlights & Community Consensus Trade Alerts - baoquankhu1.vn
Satellos Bioscience Welcomes New Chief Development Officer - GuruFocus
Satellos taps ex-Generation Bio COO to steer Duchenne trial plans - stocktitan.net
Returns Recap: How liquid is NCC.PRBC stockIPO Watch & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Why is Generation Bio Co stock going down2025 AllTime Highs & Smart Investment Allocation Insights - baoquankhu1.vn
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Halper Sadeh Investigates Shareholder Rights Violations at Diamond Hill, Generation Bio, and Contango - Intellectia AI
Investor Mood: Is Generation Bio Co a defensive stockTrade Entry Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Gap Down: Whats next for Generation Bio Co stockBreakout Watch & Long-Term Growth Plans - baoquankhu1.vn
Profit Review: Is Gen Digital Inc. in a long term uptrendEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Hedge Fund Moves: Is Generation Bio Co benefiting from innovation trendsWeekly Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Growth Value: Is Generation Bio Co benefiting from innovation trendsTake Profit & Daily Chart Pattern Signals - baoquankhu1.vn
Retail Surge: Can Vivid Seats Inc expand into new marketsJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Aug Levels: Can Generation Bio Co grow without external fundingWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Aug PostEarnings: Will Generation Bio Co outperform small cap indexesTrade Entry Summary & Daily Stock Trend Reports - baoquankhu1.vn
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—FFWM, CFLT, GBIO, and CTGO - GlobeNewswire Inc.
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of “Hold” from Analysts - Defense World
Can Generation Bio Co. stock sustain institutional interestBear Alert & Free Community Consensus Stock Picks - ulpravda.ru
Can Generation Bio Co. stock sustain revenue growthJuly 2025 Update & Growth Focused Entry Reports - Улправда
Can Generation Bio Co. stock weather global recessionJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - ulpravda.ru
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% – Here’s What Happened - Defense World
Generation Bio Co Stock (GBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):